|
NZ533370A
|
|
Use of cetyl myristate and cetyl palmitate in therapy for multiple sclerosis
|
|
NZ514536A
|
|
Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
|
|
WO03026640A1
|
|
Treating food allergies and/or food intolerances
|
|
EP1421161A1
|
|
Synthesis of ester linked long chain alkyl moieties
|
|
NZ512047A
|
|
Synthesis of ester linked long chain alkyl moieties
|
|
NZ524311A
|
|
The treatment of herpes with cetyl myristate anad cetyl palmitate
|
|
US6696491B2
|
|
Treating irritable bowel syndrome or disease
|
|
NZ522981A
|
|
Treating irritable bowel syndrome or disease
|
|
NZ522434A
|
|
Treating eczema and/or psoriasis
|
|
AU6083301A
|
|
Treating eczema and/or psoriasis
|
|
NZ507229A
|
|
Treating food allergies
|
|
NZ504526A
|
|
Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
|
|
NZ504525A
|
|
Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis
|
